| Literature DB >> 29120751 |
Abstract
Breast cancer is a heterogeneous disease, and stratification of tumors is paramount to achieve better clinical outcomes. While it is common to stratify and treat breast tumors as a single entity, insights from studies on intratumoral heterogeneity and cancer stem cells raise the possibility that multiple breast cancer subtypes may coexist within a tumor. A role for plasticity in driving dynamic conversions between breast cancer subtypes is proposed, and the clinical implications include a need for combinatorial therapeutic strategies that account for the discrete disease entities and their plasticity. Accordingly, the advent of single-cell technologies will be crucial in enabling the diagnosis and stratification of distinct disease subtypes down to the cellular level.Entities:
Keywords: breast cancer; cancer stem cells; intratumoral heterogeneity; plasticity
Mesh:
Substances:
Year: 2017 PMID: 29120751 PMCID: PMC5802368 DOI: 10.1016/j.trecan.2017.09.001
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025